Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies-Reference-Cited by-同舟云学术

Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies

Published:2021-02-17 Issue:12 Volume:127 Page:2074-2082
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jeha Sima¹^ORCID,Crews Kristine R.²,Pei Deqing³,Peyton Melissa⁴,Panetta John C.²,Ribeiro Raul C.¹,Zhao Xujie²,Campbell Patrick¹,Metzger Monika L.¹,Yang Jun J.²,Cheng Cheng³,Pui Ching‐Hon¹^ORCID,Bhojwani Deepa⁵⁶

Affiliation:

1. Department of Oncology St. Jude Children's Research Hospital Memphis Tennessee

2. Department of Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee

3. Department of Biostatistics St. Jude Children's Research Hospital Memphis Tennessee

4. Cancer Center Administration St. Jude Children's Research Hospital Memphis Tennessee

5. Children's Hospital Los Angeles Los Angeles California

6. Keck School of Medicine University of Southern California Los Angeles California

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33465

Reference27 articles.

1. Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia

2. Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

3. Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies

4. Bendamustine: Rebirth of an Old Drug

5. Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?;Frontiers in Pharmacology;2023-10-26

2. Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma;Cancer Chemotherapy and Pharmacology;2023-05-18